Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-05-08

Clinical Trial Update: Study of Wireless Nerve Stimulation in the Treatment of Chronic Migraine [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating wireless nerve stimulation for chronic migraine has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Wireless nerve stimulation device

Snippet

Sponsor: Curonix LLC | Conditions: Migraine | Phase 3 | Status: WITHDRAWN